BIOMAT Database Logo BIOMAT Database Logo

Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor. 2005

Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
Molecular Imaging Laboratory, Clinical Center, National Institutes of Allergies and Infectious Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.

Integrin alpha(v)beta(3) is a widely-recognized target for the development of targeted molecular probes for imaging pathological conditions. alpha(v)beta(3) is a cell-surface receptor protein that is upregulated in various pathological conditions including osteoporosis, rheumatoid arthritis, macular degeneration, and cancer. The synthesis of an alpha(v)beta(3)-targeted optical probe 7 from compound 1, and its in vitro and in vivo characterization is described. A series of aliphatic carbamate derivatives of the potent non-peptide integrin antagonist 1 was synthesized and the binding affinity to alpha(v)beta(3) was determined in both enzyme linked immunosorbent assay (ELISA) and cell adhesion inhibition assays. The hydrophobic carbamate-linked appendages improved the binding affinity of the parent compound for alpha(v)beta(3) by 2-20 times. A Boc-protected neopentyl derivative in the series is shown to have the best binding affinity to alpha(v)beta(3) (IC(50)=0.72 nM) when compared to compound 1 as well as to c-RGDfV. Optical probe 7 utilizes the neopentyl linker and demonstrates increased binding affinity and significant tumor cell uptake in vitro as well as specific tumor accumulation and retention in vivo. These results illustrate the potential of employing integrin-targeted molecular probes based on 1 to image a multitude of diseases associated with alpha(v)beta(3) overexpression.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
A photostable fluorescent probe for targeted imaging of tumour cells possessing integrin alpha(v)beta(3).
March 2009, Molecular bioSystems,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
Integrin alpha v beta 3-targeted imaging of lung cancer.
March 2005, Neoplasia (New York, N.Y.),
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
Integrin alpha(v)beta(3)-Targeted Cancer Therapy.
January 2008, Drug development research,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
August 2003, Cancer biotherapy & radiopharmaceuticals,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography.
May 2007, European journal of nuclear medicine and molecular imaging,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
December 2007, European journal of nuclear medicine and molecular imaging,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
October 2006, Cancer research,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.
October 2017, Molecular cancer therapeutics,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
January 2002, Bioconjugate chemistry,
Christopher A Burnett, and Jianwu Xie, and Jade Quijano, and Zhimin Shen, and Finie Hunter, and Monica Bur, and King C P Li, and S Narasimhan Danthi
In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis.
December 2019, Heart (British Cardiac Society),
Copied contents to your clipboard!